Siga Technologies (SIGA) Operating Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Operating Income came in at -$10.2 million in Q3 2025, down 1985.78% YoY from $542087.0 in Q3 2024, and down 122.38% on a QoQ basis from $45.7 million in Q2 2025.
Siga Technologies (SIGA) Operating Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Operating Income data on file, last reported at -$10.2 million in Q3 2025.
- Quarterly Operating Income fell 1985.78% year-over-year to -$10.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $90.3 million (down 13.66% YoY) and the FY2024 annual result came in at $70.0 million, down 16.31% from the prior year.
- Operating Income slipped to -$10.2 million in Q3 2025, from $45.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $94.0 million in Q4 2021 to a low of -$10.2 million in Q3 2025.
- A 5-year average of $16.8 million and a median of $1102.0 in 2021 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income jumped 278548.91% — and 2025, when it sank 1985.78%.
- Tracing SIGA's Operating Income over 5 years: stood at $94.0 million in 2021, then slumped by 101.92% to -$1.8 million in 2022, then soared by 5179.92% to $91.7 million in 2023, then sank by 37.73% to $57.1 million in 2024, then tumbled by 117.91% to -$10.2 million in 2025.
- The last three Operating Income figures came in at -$10.2 million (Q3 2025), $45.7 million (Q2 2025), and -$2.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Siga Technologies | 214.10 Mn | 59.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.22 Mn |
| Jun 30, 2025 | 45.68 Mn |
| Mar 31, 2025 | -2.26 Mn |
| Dec 31, 2024 | 57.09 Mn |
| Sep 30, 2024 | 542,087.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 91.68 Mn |
| Sep 30, 2023 | -1.31 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -1.80 Mn |
| Sep 30, 2022 | 42.87 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | -1.44 Mn |
| Dec 31, 2021 | 94.02 Mn |
| Sep 30, 2021 | -2.94 Mn |
| Jun 30, 2021 | 1,102.00 |
| Mar 31, 2021 | -1.99 Mn |
| Dec 31, 2020 | 26.80 Mn |